You are here: Industry Insights > Kantaro

News List

Kantaro Receives EUA for Semi-Quantitative COVID-19 Antibody Test Kit americanpharmaceuticalreview
December 14, 2020
Kantaro Biosciences, a joint venture between the Mount Sinai Health System and RenalytixAI, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG ...
Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies prnewswire
November 26, 2020
Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG ...
EKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the UK and Europe prnewswire
October 29, 2020
Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI plc, and manufacturing partner Bio-Techne Corporation, entered into a two-year marketing and distribution agreement with EKF Diagnostics ...